- Home
- VRE vs OCUL Comparison
VRE vs OCUL Comparison
Compare VRE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRE
- OCUL
- Stock Information
- Founded
- VRE 1949
- OCUL 2006
- Country
- VRE United States
- OCUL United States
- Employees
- VRE N/A
- OCUL N/A
- Industry
- VRE Real Estate Investment Trusts
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- VRE Real Estate
- OCUL Health Care
- Exchange
- VRE Nasdaq
- OCUL Nasdaq
- Market Cap
- VRE 1.6B
- OCUL 1.4B
- IPO Year
- VRE 1994
- OCUL 2014
- Fundamental
- Price
- VRE $17.39
- OCUL $11.09
- Analyst Decision
- VRE Hold
- OCUL Strong Buy
- Analyst Count
- VRE 3
- OCUL 8
- Target Price
- VRE $15.67
- OCUL $16.38
- AVG Volume (30 Days)
- VRE 389.4K
- OCUL 1.7M
- Earning Date
- VRE 10-30-2024
- OCUL 11-05-2024
- Dividend Yield
- VRE 1.61%
- OCUL N/A
- EPS Growth
- VRE N/A
- OCUL N/A
- EPS
- VRE N/A
- OCUL N/A
- Revenue
- VRE $292,145,000.00
- OCUL $61,097,000.00
- Revenue This Year
- VRE N/A
- OCUL $15.50
- Revenue Next Year
- VRE $4.67
- OCUL $13.26
- P/E Ratio
- VRE N/A
- OCUL N/A
- Revenue Growth
- VRE 12.90
- OCUL 11.90
- 52 Week Low
- VRE $13.07
- OCUL $2.00
- 52 Week High
- VRE $18.18
- OCUL $11.58
- Technical
- Relative Strength Index (RSI)
- VRE 49.14
- OCUL 68.96
- Support Level
- VRE $17.15
- OCUL $8.93
- Resistance Level
- VRE $17.70
- OCUL $11.58
- Average True Range (ATR)
- VRE 0.26
- OCUL 0.63
- MACD
- VRE -0.04
- OCUL 0.20
- Stochastic Oscillator
- VRE 46.07
- OCUL 84.14
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.